Pere Plans

1.1k citations
35 papers · 904 · h-index 19

Impact in

  • Hepatology top 2%
    • Hepatitis Viruses Studies and Epidemiology
    • Hepatitis C virus research
    • Liver Disease and Transplantation
    • Viral gastroenteritis research and epidemiology
    • Tuberculosis Research and Epidemiology

Papers in

    • Virology and Viral Diseases 6
    • Pneumonia and Respiratory Infections 5
    • Hepatitis B Virus Studies 4
    • Tuberculosis Research and Epidemiology 5
    • Viral gastroenteritis research and epidemiology 4
    • SARS-CoV-2 and COVID-19 Research 4

Pere Plans

34 papers receiving 869 citations

Peers

Pere Plans
Comparison fields: 5 of 88
  • Hepatology 363
  • Infectious Diseases 324
  • Epidemiology 555
  • Health 90
  • Microbiology 63
Replace Scott Grytdal with:
Scott Grytdal United States
D. C. Jain India
Antônio Alci Barone Brazil
Susan T. Goldstein United States
Josip Begovać Croatia
S.A. Uduman United Arab Emirates
Rapin Snitbhan Thailand
Gilat Livni Israel
É. Rouveix France
M. Lourdes Guerrero Mexico
Pere Plans relative to Scott Grytdal United States Scott Grytdal's profile →
Citations per field
00.5×5.3×
Scott Grytdal · 1×
Citations per year

Countries citing papers authored by Pere Plans

Since Specialization
Citations

This map shows the geographic impact of Pere Plans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pere Plans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pere Plans more than expected).

Fields of papers citing papers by Pere Plans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pere Plans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pere Plans. The network helps show where Pere Plans may publish in the future.

Co-authors

The 25 scholars most cited alongside Pere Plans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pere Plans Line = papers co-authored together Pere Plans links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1 1996100
2 199687
3 200678
4 200175
5 200064
6 200655
7 199739
8
[Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy].
199935
9 200835
10 199333
11 200928
12 200127
13 200725
14 200725
15 200724
16
[A change in the epidemiologic pattern of hepatitis A in Spain].
199223
17 199921
18 200719
19 201618
20 200414

About Pere Plans

Pere Plans is a scholar working on Epidemiology, Infectious Diseases, Hepatology, Health and Microbiology, having authored 35 papers that have together received 904 indexed citations. Recurring topics across this work include Hepatitis Viruses Studies and Epidemiology (9 papers), Vaccine Coverage and Hesitancy (8 papers), Virology and Viral Diseases (6 papers), Tuberculosis Research and Epidemiology (5 papers), Pneumonia and Respiratory Infections (5 papers), Hepatitis B Virus Studies (4 papers), Viral gastroenteritis research and epidemiology (4 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). The work is most often cited by research in Hepatology (363 citations), Infectious Diseases (324 citations), Epidemiology (555 citations), Health (90 citations) and Microbiology (63 citations). Pere Plans has collaborated with scholars based in Spain, United Kingdom and Iceland. Frequent co-authors include Ángela Domı́nguez, L. Salleras, Antoni Plasència, Josép Vidal, L. Salleras, Miquel Bruguera, L. Salleras, J. L. Taberner, J. Alcaide and Hèlios Pardell. Their work appears in journals such as Vaccine, Journal of Medical Virology, European Journal of Public Health, Medical Microbiology and Immunology and Clinical and Vaccine Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact